Table 1.

Characteristics of HMCLs classified according to HGS-ETR1 sensitivity






Death induced by HGS-ETR1 (μg/mL), %


Death induced by HGS-ETR2 (μg/mL), %

14q32 locus
IL-6
DR4, ratio
0.6
6
DR5, ratio
0.6
6
HGS-ETR1 resistant         
    ANBL-6   t(14,16)   +   1.4   1 ± 1   1 ± 1   1   1 ± 1   1 ± 1  
    BCN   t(14,16)   +   2.7   1 ± 1   1 ± 1   2.8   1 ± 1   1 ± 1  
    JJN3   t(14,16)   -   1.3   1 ± 1   1 ± 1   1.2   1 ± 1   1 ± 1  
    NAN5   t(4,14)   +   1.2   0 ± 1   2 ± 1   1   1 ± 1   2 ± 1  
    SBN   GL   +   4.3   0 ± 0   0 ± 0   1.8   12 ± 9   18 ± 1  
    XG6   GL   +   3.2   4 ± 1   5 ± 4   1.9   3 ± 3   10 ± 13  
    XG7   t(6,14)   +   1.8   3 ± 2   7 ± 7   1.9   0 ± 0   11 ± 15  
HGS-ETR1 sensitive         
    NCI-H929   t(4,14)   -   2.8   11 ± 7   17 ± 8   2.4   26 ± 4   53 ± 8  
    KMS12BM   t(11,14)   -   1.5   5 ± 4   32 ± 10   2.1   1 ± 1   5 ± 1  
    L363   GL   -   4.4   23 ± 11   31 ± 10   1.9   7 ± 3   11 ± 5  
    KMS18   t(4,14)   -   1.4   19 ± 3   39 ± 6   2.9   8 ± 4   16 ± 3  
    U266   t(11,14)   +   3.2   28 ± 5   35 ± 15   1.1   1 ± 1   1 ± 1  
    LP1   t(4,14)   -   5.4   31 ± 18   41 ± 4   2.3   1 ± 1   1 ± 1  
    NAN1   t(14,16)   +   2.2   29 ± 16   41 ± 20   2.2   1 ± 1   1 ± 1  
    NAN3   t(4,14)   +   3.5   32 ± 0   44 ± 5   1.5   1 ± 1   1 ± 1  
    XG1   t(11,14)   +   2.7   47 ± 14   51 ± 15   1.9   9 ± 6   3 ± 6  
    NAN4   GL   +   3.6   41 ± 13   58 ± 14   1.1   1 ± 2   1 ± 1  
    RPMI8226   t(14,16)   -   3.1   51 ± 18   61 ± 3   3.8   4 ± 1   10 ± 12  
    XG2   t(12,14)   +   3.2   38 ± 20   62 ± 3   1.3   1 ± 1   1 ± 1  
    XG5   t(11,14)   +   3.5   43 ± 1   68 ± 1   4.9   9 ± 4   18 ± 8  
    KMS12PE   t(11,14)   -   2.5   42 ± 7   77 ± 11   3.8   3 ± 1   14 ± 6  
    MDN
 
t(11,14)
 
+
 
3.7
 
79 ± 12
 
79 ± 7
 
1.8
 
50 ± 1
 
61 ± 21
 





Death induced by HGS-ETR1 (μg/mL), %


Death induced by HGS-ETR2 (μg/mL), %

14q32 locus
IL-6
DR4, ratio
0.6
6
DR5, ratio
0.6
6
HGS-ETR1 resistant         
    ANBL-6   t(14,16)   +   1.4   1 ± 1   1 ± 1   1   1 ± 1   1 ± 1  
    BCN   t(14,16)   +   2.7   1 ± 1   1 ± 1   2.8   1 ± 1   1 ± 1  
    JJN3   t(14,16)   -   1.3   1 ± 1   1 ± 1   1.2   1 ± 1   1 ± 1  
    NAN5   t(4,14)   +   1.2   0 ± 1   2 ± 1   1   1 ± 1   2 ± 1  
    SBN   GL   +   4.3   0 ± 0   0 ± 0   1.8   12 ± 9   18 ± 1  
    XG6   GL   +   3.2   4 ± 1   5 ± 4   1.9   3 ± 3   10 ± 13  
    XG7   t(6,14)   +   1.8   3 ± 2   7 ± 7   1.9   0 ± 0   11 ± 15  
HGS-ETR1 sensitive         
    NCI-H929   t(4,14)   -   2.8   11 ± 7   17 ± 8   2.4   26 ± 4   53 ± 8  
    KMS12BM   t(11,14)   -   1.5   5 ± 4   32 ± 10   2.1   1 ± 1   5 ± 1  
    L363   GL   -   4.4   23 ± 11   31 ± 10   1.9   7 ± 3   11 ± 5  
    KMS18   t(4,14)   -   1.4   19 ± 3   39 ± 6   2.9   8 ± 4   16 ± 3  
    U266   t(11,14)   +   3.2   28 ± 5   35 ± 15   1.1   1 ± 1   1 ± 1  
    LP1   t(4,14)   -   5.4   31 ± 18   41 ± 4   2.3   1 ± 1   1 ± 1  
    NAN1   t(14,16)   +   2.2   29 ± 16   41 ± 20   2.2   1 ± 1   1 ± 1  
    NAN3   t(4,14)   +   3.5   32 ± 0   44 ± 5   1.5   1 ± 1   1 ± 1  
    XG1   t(11,14)   +   2.7   47 ± 14   51 ± 15   1.9   9 ± 6   3 ± 6  
    NAN4   GL   +   3.6   41 ± 13   58 ± 14   1.1   1 ± 2   1 ± 1  
    RPMI8226   t(14,16)   -   3.1   51 ± 18   61 ± 3   3.8   4 ± 1   10 ± 12  
    XG2   t(12,14)   +   3.2   38 ± 20   62 ± 3   1.3   1 ± 1   1 ± 1  
    XG5   t(11,14)   +   3.5   43 ± 1   68 ± 1   4.9   9 ± 4   18 ± 8  
    KMS12PE   t(11,14)   -   2.5   42 ± 7   77 ± 11   3.8   3 ± 1   14 ± 6  
    MDN
 
t(11,14)
 
+
 
3.7
 
79 ± 12
 
79 ± 7
 
1.8
 
50 ± 1
 
61 ± 21
 

TRAIL-R1 (DR4) or TRAIL-R2 (DR5) expression was measured by FACS and expressed as the ratio of fluorescence (specific fluorescence divided by isotype control fluorescence). The percentage of specific cell death was measured after 48-hour incubation with 0.6 or 6 μg/mL HGS-ETR1 or HGS-ETR2 mAb. HMCLs cultured with IL-6 are indicated. Values of death are mean ± SD of at least 3 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal